A U.S. federal judge ruled that Abbott Laboratories' marketing of PediaSure could reasonably be interpreted as promising height growth, despite the company's claims focusing on general growth. The judge noted product packaging and advertising featuring a giraffe and ruler-like markings that suggest height increase. Abbott faces a proposed class-action lawsuit after a consumer alleged the product did not help her grandson grow taller but caused weight gain. Abbott defends its marketing as appropriate and backed by evidence, while the court allowed expert testimony supporting the plaintiff's interpretation. The case highlights scrutiny over marketing claims in children's nutritional products and could impact Abbott's advertising practices going forward.
The global market for non-invasive blood glucose monitoring devices, which measure blood sugar without needles, is projected to grow from $34.86 million in 2024 to $340.49 million by 2034, at a CAGR of 25.6%. Growth is fueled by the increasing diabet...
The global peripheral vascular devices market is projected to grow from $10.02 billion in 2026 to $13.22 billion by 2031, at a CAGR of 5.7%. Growth is fueled by rising cases of vascular disorders linked to aging, diabetes, and lifestyle factors, alon...
